Literature DB >> 16183695

Concurrent coronary and carotid artery surgery: factors influencing perioperative outcome and long-term results.

Philippe H Kolh1, Laetitia Comte, Vincent Tchana-Sato, Charles Honore, Arnaud Kerzmann, Muriel Mauer, Raymond Limet.   

Abstract

AIMS: To assess risk factors for early and late outcome after concurrent carotid endarterectomy (CEA) and coronary artery bypass grafting (CABG). METHODS AND
RESULTS: Records of all 311 consecutive patients having concurrent CEA and CABG from 1989 to 2002 were reviewed, and follow-up obtained (100% complete). In the group (mean age 67 years; 74% males), 62% had triple-vessel disease, 57% unstable angina, 31% left main coronary stenosis, 19% congestive heart failure, and 35% either a history of vascular procedures or existing vasculopathies. Preoperative assessment revealed transient ischaemic attack in 16%, stroke in 7%, and bilateral carotid disease in 20%. There were 7% emergent and 19% urgent operations, and ascending aorta was described as atheromatous or calcified in 21%. Hospital death occurred in 19 patients, myocardial infarction in seven, and permanent stroke in 12. Significant multivariable predictors of hospital death were aortic calcifications, coexisting vasculopathy, and emergent procedure. Significant predictors of postoperative stroke were calcified or dilated aorta, and of prolonged hospital stay were advanced age, unstable angina, and coexisting vascular disease. For hospital survivors, 10-year actuarial late event-free rates were: death, 50%; myocardial infarction, 84%; stroke, 93%; percutaneous angioplasty, 95%; redo CABG, 98%; and all morbidity and mortality, 48%. Significant multivariable predictors of late deaths were coexisting vasculopathy, age, renal insufficiency, previous cardiac surgery, tobacco abuse, calcified or atheromatous aorta, and duration of intensive care unit stay.
CONCLUSION: Concurrent CEA and CABG can be performed with acceptable operative mortality and morbidity, and good long-term freedom from coronary and neurologic events. Atheromatous aortic disease is a harbinger of poor operative and long-term outcome.

Entities:  

Mesh:

Year:  2005        PMID: 16183695     DOI: 10.1093/eurheartj/ehi494

Source DB:  PubMed          Journal:  Eur Heart J        ISSN: 0195-668X            Impact factor:   29.983


  7 in total

1.  Current outcomes of simultaneous carotid endarterectomy and coronary artery bypass graft surgery in North America.

Authors:  Sunil M Prasad; Shuang Li; J Scott Rankin; Sean M O'Brien; James S Gammie; John D Puskas; David M Shahian; Edgar G Chedrawy; Malek G Massad
Journal:  World J Surg       Date:  2010-10       Impact factor: 3.352

Review 2.  Effects of preoperative smoking cessation on the incidence and risk of intraoperative and postoperative complications in adult smokers: a systematic review.

Authors:  Alice Theadom; Mark Cropley
Journal:  Tob Control       Date:  2006-10       Impact factor: 7.552

Review 3.  Contemporary Management of Patients with Concomitant Coronary and Carotid Artery Disease.

Authors:  Mun J Poi; Angela Echeverria; Peter H Lin
Journal:  World J Surg       Date:  2018-01       Impact factor: 3.352

Review 4.  Should patients with asymptomatic significant carotid stenosis undergo simultaneous carotid and cardiac surgery?

Authors:  Peter Ogutu; Raphael Werner; Frank Oertel; Michael Beyer
Journal:  Interact Cardiovasc Thorac Surg       Date:  2013-12-23

5.  Association between the Gensini Score and Carotid Artery Stenosis.

Authors:  Anil Avci; Serdar Fidan; Mehmet Mustafa Tabakçı; Cuneyt Toprak; Elnur Alizade; Emrah Acar; Emrah Bayam; Muhammet Tellice; Abdurrahman Naser; Ramazan Kargın
Journal:  Korean Circ J       Date:  2016-09-28       Impact factor: 3.243

6.  Early results of combined and staged coronary bypass and carotid endarterectomy in advanced age patients in single centre.

Authors:  Hikmet Iyem; Suat Buket
Journal:  Open Cardiovasc Med J       Date:  2009-03-20

7.  Simultaneous coronary artery bypass grafting and carotid endarterectomy can be performed with low mortality rates.

Authors:  Ebuzer Aydin; Yucel Ozen; Sabit Sarikaya; Ismail Yukseltan
Journal:  Cardiovasc J Afr       Date:  2014 May-Jun       Impact factor: 1.167

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.